Usil Therapeutics
Budget
Not declared
EP Access
0
accredited persons
Staff
2
0.2 FTE
EU Grants
None
Mission & Goals
USIL Therapeutics is a Luxembourg-based biotech company developing fast-deployable radioprotective solutions for defense, nuclear, and space applications.
EU Legislative Interests
Some Usil's team members are meeting DG HERA to better support the institution's request to help the development of CBRN medical countermeasures. In particular, there is a meeting planned on November 6th in Brussels entitled HERA CBRN quantification workshop we will attend to present our activities and technical solutions.
Communication Activities
None.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
None.
Organisation Members
None.
Commissioner Meetings
No recorded meetings with EU commissioners.